Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 26, 2026
Resolutions from the Annual General Meeting of Novo Nordisk A/S
View original at finance.yahoo.comResolutions from the Annual General Meeting of Novo Nordisk A/S Novo Nordisk A/S Bagsværd, Denmark, 26 March 2026 – Today, Novo Nordisk A/S held its Annual General Meeting…
Ce que nous avons tiré de cette source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Novo Nordisk is reshaping its traditional approach to patient care and market access, needing to meet patients where they are
60% confidenceThe year ahead will test Novo Nordisk's determination and capabilities, but the company faces it with confidence
60% confidenceNovo Nordisk's renewed focus, strengthened competencies and commitment to people with serious chronic diseases position them well for challenges and opportunities ahead
60% confidence2025 was a year of profound transformation for Novo Nordisk
60% confidence
Data points we hold from this source
| Novo Nordisk A/S · final dividend per share | 7.95 DKK |
| Novo Nordisk A/S · dividend per share | 11.70 DKK |
| Novo Nordisk A/S · share par value | 0.10 DKK |
| Novo Nordisk A/S · authorized share repurchase limit | 10 percent |
| Novo Nordisk A/S · authorized share capital increase | 44650000 DKK |
| Novo Nordisk A/S · interim dividend per share | 3.75 DKK |
